United States

Synonyms: 
USA
the states
the US
Mon
20
Jul

It's High Time To Clean Up The CBD Industry

Last week, the FDA released a report to Congress on their findings after randomly testing a broad range of CBD brands and products on the market. The findings were shocking: More than half the CBD products tested were inaccurately labeled, in many cases containing significantly more or less CBD than indicated on the packaging. Alarmingly, nearly half of the CBD products tested were found to contain the psychoactive compound found in recreational and medical cannabis—THC.

Mon
20
Jul

Will The U.S. Hemp Industry Ever Be Its Own Industry?

 

Fri
17
Jul

Is CBN A Controlled Substance? Yes. No. Maybe.

Some commentators argue that CBN, regardless of its source, is a controlled substance because it is produced from the degradation of THC.

Earlier this year, we discussed the legality of lesser-known hemp-derived cannabinoids which appeared to be gaining success in the U.S. One of these promising cannabinoids is cannabinol (“CBN”).

Fri
17
Jul

Petition Pushing For Higher Permitted Hemp THC Levels

The U.S hemp community has been urged to get cracking on signing a petition calling for the legal definition of hemp to be changed to allow for 1% THC.

Under the 2018 Farm Bill, hemp is defined as cannabis not containing more than 0.3 percent of the intoxicating cannabinoid tetrahydrocannabinol (THC). How that percentage was arrived at, which was apparently set by a Canadian cannabis researcher way back in the 1970s, is somewhat a mystery given even at much higher levels industrial hemp still wouldn’t have any recreational value.

The 0.3% limit has cause headaches for the industry as hemp testing above that level must be destroyed. For example, we mentioned yesterday half of Hawai’i’s 2019 hemp crop was destroyed due to elevated THC levels.

Fri
17
Jul

VA mental health commission recommends federal cannabis research

Many government officials are comparatively skittish about supporting cannabis and its synthetic counterparts because of its Class 1 drug status, even for the treatment of COVID-19. That being the case, there was recently some surprising news from an association that may have made some people in the U.S. federal government sit up and take notice.

Thu
16
Jul

U.S FDA Releases Cannabidiol Testing Results

Recent testing carried out by the FDA on cannabis products shows there’s still a lot to be desired in product quality control.

The FDA has been undertaking a more extensive CBD product sampling effort this year to help it fill gaps in knowledge and to respond to a direction from Congress to determine prevalence of mislabeled or adulterated products in the current CBD marketplace.

The FDA first generated a list of 500 marketed CBD and hemp products. From that list, which included products where CBD wasn’t mentioned, 200 products were purchased across a number of categories – tincture/oil, capsule/powder, gummy, other edibles and pet products (tinctures, oils and drops).

Thu
16
Jul

Using cannabis not associated with heart abnormalities at middle age: study

Occasional current and lifetime cumulative use of cannabis are not associated with increases in heart abnormalities at middle age, suggests a new study by researchers from Switzerland and the U.S.

Wed
15
Jul

Senator predicts U.S. will legalize weed next year if Dems gain control of Congress

With the House already under Democrat control, and polls indicating Joe Biden has a lead over President Donald Trump nationwide, marijuana reform could be closer than anticipated. 

In an interview on the Young Jurks podcast, former anti-legalization Massachusetts senator Ed Markey spoke at length about marijuana reform, suggesting that Congress is close to legalizing cannabis. 

Tue
14
Jul

The Latest Report From The FDA Shows How Poorly It Has Handled CBD

As it stands, the FDA has been very vocally opposed to Hemp CBD products without imposing any real penalties.

Tue
14
Jul

The evolution of cannabis in the US

As the National Cannabis Industry Association celebrates its 10th anniversary, CEO Aaron Smith tells MCN about the evolution of cannabis in the US.

Aaron Smith is the CEO and co-founder of the National Cannabis Industry Association (NCIA), the USA’s largest trade organisation for legal cannabis businesses. The NCIA was founded in 2010 with the goals of advocating for policy reform, providing educational resources and acting as a voice for the burgeoning legal cannabis sector in the US.

Pages

Subscribe to RSS - United States